Sanofi has begun a comprehensive review of compounds, leads, patents and technologies in our pipeline.
Our objective is to identify those with potential for out-licensing or other appropriate forms of partnering. This is a new initiative to create long-term value. We are flexible, and as we progress in our review, we will be open to exchanging ideas towards establishing creative partnerships.
Partnering press releases
March 25, 2013
© Sanofi 2004-2013 - All rights reserved - Update: January 18, 2013